It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat mitral regurgitation (mr).An unknown mitraclip was implanted.At the 30 day follow up, the mitraclip was observed to be detached from one leaflet (single leaflet device attachment (slda)) resulting in recurrent mr.On (b)(6) 2023 ,the patient underwent mitral valve replacement surgery.The patient is reported to be stable.The physician thought the slda was related to the patient's functional anatomy.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.All available information was investigated, and the reported single leaflet device attachment (slda) per the physician is related to patient anatomy.The reported mr is a cascading effect of the reported incomplete coaptation.Additionally, the reported patient effect of mitral regurgitation is listed in the instructions for use, and is a known possible complication associated with mitraclip procedures.The reported hospitalization and surgical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|